Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 2,220 | 833 | 1,071 | 1,180 | 1,451 |
| Cost of Goods | 701 | 759 | 354 | 747 | 668 |
| Gross Profit | 1,519 | 74 | 717 | 433 | 783 |
| Operating Expenses | 28,062 | 22,113 | 21,196 | 21,377 | 23,018 |
| Operating Income | -25,842 | -21,280 | -20,125 | -20,197 | -21,567 |
| Interest Expense | 2,157 | 2,134 | 2,128 | 2,145 | 2,180 |
| Other Income | 51 | 102 | 298 | 384 | 571 |
| Pre-tax Income | -27,948 | -23,312 | -21,955 | -21,958 | -23,176 |
| Net Income Continuous | -27,948 | -23,312 | -21,955 | -21,958 | -23,176 |
| Net Income | $-27,948 | $-23,312 | $-21,955 | $-21,958 | $-23,176 |
| EPS Basic Total Ops | -25.00 | -21.00 | -27.00 | -31.50 | -34.00 |
| EPS Basic Continuous Ops | -24.94 | -20.92 | -26.93 | -31.35 | -33.91 |
| EPS Diluted Total Ops | -25.00 | -21.00 | -27.00 | -31.50 | -34.00 |
| EPS Diluted Continuous Ops | -24.94 | -20.92 | -26.93 | -31.35 | -33.91 |
| EBITDA(a) | $-25,353 | $-20,796 | $-19,642 | $-19,719 | $-21,098 |